SurgePays, Inc.
US ˙ NasdaqCM ˙ US86882L2043

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kevin Brian Cox. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Kevin Brian Cox has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SURG / SurgePays, Inc. CEO and Chairman of Board, Director 5,785,163
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kevin Brian Cox. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SURG / SurgePays, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SURG / SurgePays, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-05-16 SURG Cox Kevin Brian 15,073 2.7500 15,073 2.7500 41,451 53 3.4300 10,250 24.73
2023-08-15 SURG Cox Kevin Brian 5,200 4.7200 5,200 4.7200 24,544
2022-08-31 SURG Cox Kevin Brian 5,000 4.3000 5,000 4.3000 21,500
2022-08-18 SURG Cox Kevin Brian 5,000 4.7800 5,000 4.7800 23,900
2022-08-18 SURG Cox Kevin Brian 2,000 4.7300 2,000 4.7300 9,460
2022-06-02 SURG Cox Kevin Brian 4,900 4.3900 4,900 4.3900 21,511
2021-09-09 SURG Cox Kevin Brian 500,000 0.1000 10,000 5.0000 50,000
2021-02-24 SURG Cox Kevin Brian 120,000 0.1554 2,400 7.7700 18,648
2021-01-07 SURG Cox Kevin Brian 21,298 0.1130 426 5.6500 2,407
2020-12-28 SURG Cox Kevin Brian 120,000 0.1500 2,400 7.5000 18,000
2020-12-04 SURG Cox Kevin Brian 100,000 0.1500 2,000 7.5000 15,000
2020-11-10 SURG Cox Kevin Brian 162,054 0.1240 3,241 6.2000 20,095
2020-11-05 SURG Cox Kevin Brian 87,500 0.0850 1,750 4.2500 7,438
2020-11-04 SURG Cox Kevin Brian 157,559 0.0800 3,151 4.0000 12,605
2020-10-28 SURG Cox Kevin Brian 4,900 0.0925 98 4.6250 453
2020-10-27 SURG Cox Kevin Brian 250,000 0.1000 5,000 5.0000 25,000
2020-10-22 SURG Cox Kevin Brian 126,800 0.1000 2,536 5.0000 12,680
2020-10-16 SURG Cox Kevin Brian 5,625 0.1100 112 5.5000 619

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SURG / SurgePays, Inc. Insider Trades
Insider Sales SURG / SurgePays, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SURG / SurgePays, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2024-12-03 SURG Cox Kevin Brian 35,180 1.8216 35,180 1.8216 64,084 91 1.1300 -24,330 -37.97
2024-11-04 SURG Cox Kevin Brian 31,700 1.5950 31,700 1.5950 50,562
2024-10-02 SURG Cox Kevin Brian 32,375 1.7516 32,375 1.7516 56,708
2024-09-03 SURG Cox Kevin Brian 35,100 1.4782 35,100 1.4782 51,885
2024-08-02 SURG Cox Kevin Brian 33,600 2.5990 33,600 2.5990 87,326
2024-07-02 SURG Cox Kevin Brian 20,915 3.0517 20,915 3.0517 63,826

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SURG / SurgePays, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kevin Brian Cox as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-05-19 2025-05-16 4 SURG SurgePays, Inc.
Shares of Common Stock) 		P - Purchase 15,073 5,785,163 0.26 2.75 41,451 15,909,198
2024-12-04 2024-12-03 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -35,180 5,770,090 -0.61 1.82 -64,084 10,510,796
2024-11-15 2024-11-04 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -31,700 5,805,270 -0.54 1.60 -50,562 9,259,406
2024-10-03 2024-10-02 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -32,375 5,836,970 -0.55 1.75 -56,708 10,224,037
2024-10-03 2024-10-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,333 5,869,345 1.44
2024-09-04 2024-09-03 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -35,100 5,786,012 -0.60 1.48 -51,885 8,552,883
2024-09-04 2024-09-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,333 5,821,112 1.45
2024-08-05 2024-08-02 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -33,600 5,737,779 -0.58 2.60 -87,326 14,912,488
2024-08-05 2024-08-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,333 5,771,379 1.47
2024-07-03 2024-07-02 4 SURG SurgePays, Inc.
Shares of Common Stock) 		S - Sale -20,915 5,688,046 -0.37 3.05 -63,826 17,358,210
2024-07-03 2024-07-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,333 5,708,961 1.48
2024-06-04 2024-06-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,334 5,620,428 1.51
2024-05-03 2024-05-01 4 SURG SurgePays, Inc.
Restricted Shares (Common Stock) 		A - Award 83,334 5,537,094 1.53
2023-08-16 2023-08-15 4 SURG SurgePays, Inc.
Common Stock, $0.001 par value per share 		P - Purchase 5,200 4,507,894 0.12 4.72 24,544 21,277,260
2022-12-30 2022-12-28 4 SURG SurgePays, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 1,050,000 4,502,694 30.41
2022-09-01 2022-08-31 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 5,000 3,452,694 0.15 4.30 21,500 14,846,584
2022-08-19 2022-08-18 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 2,000 3,449,694 0.06 4.73 9,460 16,317,053
2022-08-19 2022-08-18 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 5,000 3,447,694 0.15 4.78 23,900 16,479,977
2022-06-03 2022-06-02 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 4,900 3,442,694 0.14 4.39 21,511 15,113,427
2022-06-03 2021-11-11 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		J - Other 561,758 561,758
2022-06-03 2021-11-11 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		C - Conversion 3,016,820 3,437,794 716.63
2021-09-14 2021-09-09 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 500,000 21,048,724 2.43 0.10 50,000 2,104,872
2021-03-01 2021-02-24 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 120,000 20,548,724 0.59 0.16 18,648 3,193,272
2021-01-11 2021-01-07 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 21,298 20,450,022 0.10 0.11 2,407 2,310,852
2021-01-11 2020-12-28 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 120,000 20,428,724 0.59 0.15 18,000 3,064,309
2020-12-07 2020-12-04 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 100,000 20,308,724 0.49 0.15 15,000 3,046,309
2020-11-13 2020-11-10 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 162,054 20,208,724 0.81 0.12 20,095 2,505,882
2020-11-05 2020-11-05 4 SURG SurgePays, Inc.
Common stock, $0.001 par value per share 		P - Purchase 87,500 20,046,670 0.44 0.08 7,438 1,703,967
2020-11-04 2020-11-04 4 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		P - Purchase 157,559 19,959,170 0.80 0.08 12,605 1,596,734
2020-10-30 2020-10-27 4 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		P - Purchase 250,000 19,796,711 1.28 0.10 25,000 1,979,671
2020-10-30 2020-10-28 4 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		P - Purchase 4,900 19,801,611 0.02 0.09 453 1,831,649
2020-10-28 2020-10-22 4 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		P - Purchase 126,800 19,546,711 0.65 0.10 12,680 1,954,671
2020-10-20 2020-10-16 4 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		P - Purchase 5,625 19,419,911 0.03 0.11 619 2,136,190
2020-10-09 3 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		19,414,286
2020-10-09 3 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		4,813,885
2020-10-09 3 SURG Surge Holdings, Inc.
Common stock, $0.001 par value per share 		1,800,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)